Aclaris Therapeutics, Inc. (ACRS) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Aclaris Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -5.69x | -1.45x | -0.83x | -11.82x | -9.08x | -5.40x |
| P/B Ratio | 3.58x | 1.23x | 0.47x | 5.20x | 4.18x | 7.31x |
| P/S Ratio | 47.18x | 10.24x | 2.35x | 34.52x | 122.00x | 42.46x |
| Profitability | ||||||
| Gross Margin | 73.3% | 85.1% | 42.1% | 59.8% | 30.3% | 20.8% |
| Operating Margin | -975.9% | -758.2% | -311.6% | -302.0% | -1327.1% | -785.4% |
| Net Margin | -829.6% | -705.5% | -283.1% | -292.1% | -1344.0% | -787.0% |
| EBITDA Margin | -823.8% | -276.3% | -369.5% | -283.5% | -953.4% | -728.1% |
| Liquidity | ||||||
| Current Ratio | 5.28x | 3.99x | 4.16x | 10.55x | 8.94x | 3.87x |
| Quick Ratio | 5.28x | 3.99x | 4.16x | 10.55x | 8.94x | 3.87x |
| Leverage | ||||||
| Debt/Equity | 0.02x | 0.00x | 0.00x | 0.00x | 0.00x | 0.30x |
YoY = year-over-year change. Source: FMP..